Lv1
40 积分 2025-09-22 加入
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
13天前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
14天前
已完结
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
1个月前
已完结
Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
2个月前
已完结
Acalabrutinib for treatment of steroid-refractory chronic graft vs. host disease
2个月前
已完结
Evolution of mantle cell lymphoma therapy: advancing frontline precision
2个月前
已完结
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial
2个月前
已完结
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
4个月前
已完结
Chronic myelomonocytic leukemia - a review
4个月前
已完结
皖公网安备34019202002308
